FIT

ASGE Journal ScanKolon

Cancers Detected in Second-Round Fecal Immunochemical Test Screening Still Early Stage

Cancers Detected in Second-Round Fecal Immunochemical Test Screening Still Early Stage

The value of colorectal cancer (CRC) screening lies in CRC prevention through polyp detection and prevention of CRC mortality by early-stage CRC detection. Compared with

ASGE Journal ScanKolon

Delay in Colonoscopy After Positive FIT May Be Lethal, Particularly in 40- to 49-Year-Olds

Delay in Colonoscopy After Positive FIT May Be Lethal, Particularly in 40- to 49-Year-Olds

These data are from a population-based Chinese screening program involving 595,180 persons aged 40 to 74 years with 16 years of follow-up. There were 42,353

ASGE Journal ScanKolon

Offering a Blood Test Increases CRC Screening in Patients Who Had Declined Colonoscopy and FIT

Offering a Blood Test Increases CRC Screening in Patients Who Had Declined Colonoscopy and FIT

This was a randomized controlled trial in 359 veterans aged 50 to 75 years who had declined colonoscopy and a fecal immunochemical test (FIT) in

ASGE Journal ScanKolon

Anticoagulant and Antiplatelet Agents Affect Fecal Immunochemical Test Performance

Anticoagulant and Antiplatelet Agents Affect Fecal Immunochemical Test Performance

In a very large study, 11.8% of 77,007 patients receiving antithrombotic treatment had a positive fecal immunochemical test (FIT) result, compared with 6% of those

ASGE Journal ScanKolon

Colorectal Cancer Screening Rates Increased During the COVID Pandemic, but With Stool-based Tests, Not Colonoscopy

Colorectal Cancer Screening Rates Increased During the COVID Pandemic, but With Stool-based Tests, Not Colonoscopy

This report is from the National Health Interview Survey, an annual survey of U.S. households covering a wide range of health topics. Response rates were

ASGE Journal ScanMagen und Dünndarm

Is There an Increased Risk of Proximal Gastrointestinal Cancer After a Positive Fecal Immunochemical Test?

Is There an Increased Risk of Proximal Gastrointestinal Cancer After a Positive Fecal Immunochemical Test?

The fecal immunochemical test (FIT) is a simple, noninvasive, at-home study that detects blood in the stool and is used for colon cancer (CRC) screening

ASGE Journal ScanKolon

ADR Works in FIT-Positive Populations: Target ADR Must Be Substantially Higher Than Primary Screening ADR

ADR Works in FIT-Positive Populations: Target ADR Must Be Substantially Higher Than Primary Screening ADR

It is well known that the prevalence of adenomas is higher in patients with a positive result from a stool test, including both the fecal

ASGE Journal ScanKolon

Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program

Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program

In 2014, the Netherlands instituted a national program of every-other-year fecal immunochemical test (FIT) screening for colorectal cancer (CRC). Since the start of screening, within

ASGE Journal ScanKolon

Risk-Stratified CRC Screening Using Fecal Immunochemical Test and Stool DNA

Risk-Stratified CRC Screening Using Fecal Immunochemical Test and Stool DNA

This is a post hoc analysis of a risk-stratification screening strategy based on the Asia-Pacific Colorectal Screening (APCS) scoring system. This score ranks patients as

ASGE Journal ScanKolon

Adenoma Detection Rate Says It All in FIT-Positive Patients

Adenoma Detection Rate Says It All in FIT-Positive Patients

This is a study of detection indicators in 13,067 fecal immunochemical test (FIT)-positive colonoscopies performed by 80 community gastroenterologists. The cutoff for FIT positivity was

ASGE Journal ScanKolon

Actual Impact of COVID-19 on CRC (8.7% Reduction) and Advanced Adenoma (26.9% Reduction) Diagnoses in a U.S. Health Care System

Actual Impact of COVID-19 on CRC (8.7% Reduction) and Advanced Adenoma (26.9% Reduction) Diagnoses in a U.S. Health Care System

This study utilized the Kaiser Permanente Northern California (KPNC) health care system to evaluate the actual impact of the COVID-19 pandemic on colorectal cancer (CRC).

ASGE Journal ScanKolon

Computer-Aided Detection Improves Adenoma Detection Rate and Adenomas Per Colonoscopy in Fecal Immunochemical Test-Positive Patients

Computer-Aided Detection Improves Adenoma Detection Rate and Adenomas Per Colonoscopy in Fecal Immunochemical Test-Positive Patients

In parallel-arm randomized trials involving mostly primary screening and surveillance colonoscopy patients, computer-aided detection (CADe) has increased the adenoma detection rate (ADR) by about 10%.

ASGE Journal ScanKolon

Systematic Review and Meta-analysis of Adenoma Detection Rates in FIT-positive Patients

Systematic Review and Meta-analysis of Adenoma Detection Rates in FIT-positive Patients

The U.S. Multi-Society Task Force on Colorectal Cancer recommends minimally acceptable adenoma detection rates (ADRs) in primary screening colonoscopy of 30% in men and 20%

ASGE Journal ScanKolon

The Veterans Health Administration Instituted a National Policy Converting Screening Colonoscopy to FIT During the COVID Pandemic: Was the Policy Followed?

The Veterans Health Administration Instituted a National Policy Converting Screening Colonoscopy to FIT During the COVID Pandemic: Was the Policy Followed?

During the COVID-19 pandemic, the Veterans Health Administration (VHA) instituted a national policy converting screening colonoscopy to fecal immunochemical testing (FIT) to manage reduced access

ASGE Journal ScanKolon

Endocuff Vision Effective in “Real-World” Experience

Endocuff Vision Effective in “Real-World” Experience

Endocuff Vision (ECV; Olympus America, Center Valley, Pa) has produced adenoma detection rate (ADR) gains in randomized controlled trials, but it has not received widespread

ASGE Journal ScanKolon

Protein Assays Added to the Fecal Immunochemical Test Improve Sensitivity for Advanced Adenomas

Protein Assays Added to the Fecal Immunochemical Test Improve Sensitivity for Advanced Adenomas

The fecal immunochemical test (FIT) is widely chosen by organized colorectal cancer (CRC) screening programs as the screening test of choice. FIT detects about 80%

ASGE Journal ScanKolon

Colonoscopy More Effective Than the Fecal Immunochemical Test in Case-Control Study

Colonoscopy More Effective Than the Fecal Immunochemical Test in Case-Control Study

Randomized controlled trials comparing the use of colonoscopy to the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening are underway.   A case-control study from

ASGE Journal ScanKolon

Bad Outcomes for Patients Not Undergoing Colonoscopy After Positive Fecal Immunochemical Test

Bad Outcomes for Patients Not Undergoing Colonoscopy After Positive Fecal Immunochemical Test

In an Italian study using a fecal immunochemical test (FIT)-positivity cutoff of 20 µg Hb/g feces, 88,013 FIT-positive patients (79%) underwent colonoscopy, and 23,410 (21%)

ASGE Journal ScanKolon

Adherence To Colonoscopy After Positive Fecal Immunochemical Testing Is Related To Patient Navigation and Distance From Center

Adherence To Colonoscopy After Positive Fecal Immunochemical Testing Is Related To Patient Navigation and Distance From Center

In a comparison of colonoscopy adherence after positive fecal immunochemical testing (FIT) in 2017 without patient navigation (PN) versus 2018 with navigation, overall completion of

ASGE Journal ScanKolon

Adenoma Detection Rate Can Be Measured in Combined Screening, Surveillance, and Diagnostic Examinations

Adenoma Detection Rate Can Be Measured in Combined Screening, Surveillance, and Diagnostic Examinations

When the adenoma detection rate (ADR) was originally proposed as a quality measure in 2002, the recommendation did not constrain its indication to screening colonoscopies

ASGE Journal ScanKolon

Screening With Fecal Immunochemical Test More Impactful for Distal Than Proximal Cancers

Screening With Fecal Immunochemical Test More Impactful for Distal Than Proximal Cancers

In a nationwide biennial fecal immunochemical test (FIT) screening program in Taiwan, more than 5.4 million individuals were invited to undergo screening between 2004 and

ASGE Journal ScanKolon

Kaiser Achieved Greater Than 80% Screening Adherence; How Did They Do It?

Kaiser Achieved Greater Than 80% Screening Adherence; How Did They Do It?

Organized screening, in which a nation or health care system systematically offers colorectal cancer screening for eligible patients, usually by fecal immunochemical testing (FIT), is

ASGE Journal ScanKolon

Negative Colonoscopy for FIT-Positive Patients: Should We Keep Doing FIT?

Negative Colonoscopy for FIT-Positive Patients: Should We Keep Doing FIT?

In this study from Taiwan, patients with a negative colonoscopy after a positive fecal immunochemical test (FIT) during the interval 2004 through 2009 were followed

ASGE Journal ScanKolon

Risk of Death From Colonoscopy in the Italian FIT Screening Program

Risk of Death From Colonoscopy in the Italian FIT Screening Program

Organized fecal immunochemical test (FIT)-based screening programs offer the opportunity to prospectively assess adverse events of colonoscopy. A recent large study from the Netherlands found

ASGE Journal ScanKolon

Early Colorectal Cancer Screening in African Americans: High Uptake and High Yield

Early Colorectal Cancer Screening in African Americans: High Uptake and High Yield

Recommendations from GI societies to screen African Americans for colorectal cancer (CRC) starting at age 45 were based largely on age-related incidence and mortality data

ASGE Journal ScanKolon

Considering Endoscopy in Iron Deficiency Anemia? Don’t Rely on Fecal Blood Testing to Decide

Considering Endoscopy in Iron Deficiency Anemia? Don’t Rely on Fecal Blood Testing to Decide

Douglas K. Rex, MD, FASGE, reviewing Lee MW, et al. Am J Gastroenterol 2020 Jan 10. Fecal blood testing is approved as a colorectal cancer

ASGE Journal ScanKolon

Improving the Message of Mailed Outreach Improves CRC Screening Adherence

Improving the Message of Mailed Outreach Improves CRC Screening Adherence

Douglas K. Rex, MD, FASGE, reviewing Bakr O, et al. Clin Transl Gastroenterol 2020 Jan. Mailed outreach, in which a fecal immunochemical test (FIT) kit